Application of Modeling to Scale-up Liquid Mixing Processes

Thursday, November 12, 2009: 12:55 PM
Bayou A (Gaylord Opryland Hotel)

Venkat R. Koganti, Parenteral Center of Emphasis, Pfizer Global Research and Development, Groton, CT
Fred Carroll, Pgrd, Pfizer Global Research and Development, Groton, CT
Richard Ferraina, Pgrd, Pfizer Global Research and Development, Groton, CT
Mark Berry, Pgrd, Pfizer Global Research and Development, Groton, CT
Robert Leasure, Pgm, Pfizer Global Research and Development, Groton, CT
Jeffrey Gaudio, Pgm, Pfizer Global Research and Development, Groton, CT
Yang Liu, Pgrd, Pfizer Global Research and Development, Groton, CT
Kenneth Norris, Pgrd, Pfizer Global Research and Development, Groton, CT
Bryan Braxton, Pgrd, Pfizer Global Research and Development, Groton, CT
WIlliam Petre, Pgrd, Pfizer Global Research and Development, Groton, CT
Yogesh Waghmare, Bend Research Inc, Bend, OR
Rick Falk, Bend Research Inc, Bend, OR

Scale-up of liquid mixing is usually done empirically without considering the several factors like dissolution theory, equipment differences between scales and so on. In this work we present a systematic way to scale-up liquid mixing processes utilizing both Design of Experiment (DoE) approach to identify the operating space (effect of operating parameters) and Computational Fluid Dynamics modeling to scale the mixing dynamics from laboratory to commercial scale. Underlying principles of modeling and also experimental data on dissolution at different scales for model solutes will be presented. This work also serves as an example of utilizing Quality by Design principles in designing the operating space during drug product manufacturing process design.
Extended Abstract: File Not Uploaded